Skip to main content
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2000 Nov;92(11):507–514.

Making medicines for America: the case for clinical trial diversity.

J H Powell 1, Y Fleming 1
PMCID: PMC2568328  PMID: 11152082

Full text

PDF
507

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gamble V. N. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997 Nov;87(11):1773–1778. doi: 10.2105/ajph.87.11.1773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Kalow W. Interethnic variation of drug metabolism. Trends Pharmacol Sci. 1991 Mar;12(3):102–107. doi: 10.1016/0165-6147(91)90516-u. [DOI] [PubMed] [Google Scholar]
  3. Ratain J. S., Hochberg M. C. Clinical trials. A guide to understanding methodology and interpreting results. Arthritis Rheum. 1990 Jan;33(1):131–139. doi: 10.1002/art.1780330118. [DOI] [PubMed] [Google Scholar]
  4. Svensson C. K. Representation of American blacks in clinical trials of new drugs. JAMA. 1989 Jan 13;261(2):263–265. [PubMed] [Google Scholar]
  5. Swanson G. M., Ward A. J. Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst. 1995 Dec 6;87(23):1747–1759. doi: 10.1093/jnci/87.23.1747. [DOI] [PubMed] [Google Scholar]
  6. Wermeling D. P., Selwitz A. S. Current issues surrounding women and minorities in drug trials. Ann Pharmacother. 1993 Jul-Aug;27(7-8):904–911. doi: 10.1177/106002809302700719. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES